文献速递肝胆胰外科围术期管理与 ERAS

纳米孔测序用于胆管培养的可行性临床研究

"Answers in hours": A prospective clinical study using nanopore sequencing for bile duct cultures.
PubMed 文献 · Surgery · 2021-12-29

本研究纳入42例胰头切除术患者,比较术中胆汁标准培养与纳米孔测序的微生物谱及抗生素推荐。纳米孔测序检出更多菌种(10.5 vs 4.4)和耐药基因(10.3 vs 2.7),结果更快(8 vs 98小时)但成本更高(165 vs 38.49美元),阴性预测价值完美,有望改善抗生素管理。

要点

  • 纳米孔测序检出菌种数10.5 vs 标准培养4.4(p<0.05)。
  • 纳米孔测序检出耐药基因数10.3 vs 标准培养2.7(p<0.05)。
  • 纳米孔测序结果时间8 vs 标准培养98小时,成本165 vs 38.49美元。

核心结论

  • 纳米孔测序用于术中胆汁微生物谱分析可行,较标准培养提供更广泛的菌种和耐药谱,阴性预测价值完美,可能改善抗生素管理。

研究设计与样本

  • 前瞻性临床研究,纳入42例接受胰头切除术的患者,比较术中胆汁标准培养与纳米孔测序的微生物谱、耐药模式、抗生素推荐及结果时间。

主要发现

  • 42例中22例(52%)标准培养阳性,所有阳性样本纳米孔测序均检出微生物;20例标准培养阴性者纳米孔测序均阴性。
  • 纳米孔测序检出菌种数10.5 vs 标准培养4.4(p<0.05),耐药基因数10.3 vs 标准培养2.7(p<0.05)。
  • 基于纳米孔测序的抗生素推荐在44份样本中27份(61%)覆盖标准培养结果,其中13份(48%)推荐更广覆盖。
  • 纳米孔测序结果时间8 vs 标准培养98小时,成本165 vs 38.49美元。

临床怎么用

  • 纳米孔测序可快速提供术中胆汁微生物及耐药信息,阴性预测价值完美,可能辅助抗生素管理决策。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Surgical site infection is a major source of morbidity in patients undergoing pancreatic head resection and is often from organisms in intraoperative bile duct cultures. As such, many institutions use prolonged prophylactic antibiotics and tailor based on bile duct cultures. However, standard cultures take days, leaving many patients unnecessarily on prolonged antibiotics. Nanopore sequencing can provide data in hours and, thus, has the potential to improve antibiotic stewardship. The present study investigates the feasibility of nanopore sequencing in intraoperative bile samples. METHODS: Patients undergoing pancreatic head resection were included. Intra-operative bile microbial profiles were determined with standard cultures and nanopore sequencing. Antibiotic recommendations were generated, and time-to-results determined for both methods. Organism yields, resistance patterns, antibiotic recommendations, and costs were compared. RESULTS: Out of 42 patients, 22 (52%) had samples resulting in positive standard cultures. All positive standard cultures had microbes detected using nanopore sequencing. All 20 patients with negative standard cultures had negative nanopore sequencing. Nanopore sequencing detected more bacterial species compared to standard cultures (10.5 vs 4.4, p < 0.05) and more resistance genotypes (10.3 vs 2.7, p < 0.05). Antimicrobial recommendations based on nanopore sequencing provided coverage for standard cultures in 27 out of 44 (61%) samples, with broader coverage recommended by nanopore sequencing in 13 out of 27 (48%) of these samples. Nanopore sequencing results were faster (8 vs 98 hours) than standard cultures but had higher associated costs ($165 vs $38.49). CONCLUSION: Rapid microbial profiling with nanopore sequencing is feasible with broader organism and resistance profiling compared to standard cultures. Nanopore sequencing has perfect negative predictive value and can potentially improve antibiotic stewardship; thus, a randomized control trial is under development.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Yonkus JA, Whittle E, Alva-Ruiz R, et al. "Answers in hours": A prospective clinical study using nanopore sequencing for bile duct cultures. Surgery. 2021. PMID: 34973809. doi:10.1016/j.surg.2021.09.037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。